News

Home/News

Deepmed IO and Inspirata Partnership

By |2020-05-14T14:50:56+03:00May 14th, 2020|Categories: News|Tags: |

We are excited to announce our new technical partnership with Inspirata! DeepPath™, DeepMed IO's AI-powered Metastasis Detection Technology can now be integrated into Inspirata's Dynamyx™ through its open API. Dynamyx™ streamlines case management, facilitates communication and accelerates pathology workflows, while DeepPath™ uses AI to offer decision support for faster and more accurate staging as determined by [...]

We are extremelly exited because on November 27, 2019 our team made its 3rd submission to the #camelyon17 Grand Challenge achieving a k of 90.52%!

By |2019-11-27T16:57:00+02:00November 27th, 2019|Categories: News|

We are extremelly exited because on November 27, 2019 our team made its 3rd submission to the #camelyon17 Grand Challenge achieving a k of 90.52%! This makes our solution the 5th best submitted one in the world among 62 teams and 98 submissions. It must be mentioned that there are only 3 companies present including DeepMed [...]

DeepMed.io: One of many AI start-ups benefitting from Nvidia’s Inception Program

By |2019-11-26T10:59:43+02:00November 26th, 2019|Categories: News|

As part of the Nvidia Inception Program, the UK start-up has used AI to help pathologists classify and detect breast cancer in tissue samples Artificial intelligence and machine learning are being used increasingly in the healthcare industry to make life easier for doctors and improve patient outcomes (Credit: Pixabay) One of the biggest challenges for any [...]

DeepMed IO at the European Pathology Conference 2019 in Nice.

By |2019-09-13T21:26:06+03:00September 13th, 2019|Categories: News|

Dr. Konstantinos Vougas from DeepMed IO attended the #symposium of #computational #pathology of the European #pathology Conference at Nice. It was a great experience watching all the high-quality engaging talks and a great honor meeting key influencers in the field like Dina Tiniakos(Professor of Pathology at National & Kapodistrian University of Athens and President of the [...]

DeepMed IO makes it to the top 10 teams in the world in metastasis detection on breast cancer using AI.

By |2019-09-06T14:31:37+03:00September 5th, 2019|Categories: News|

We are happy to announce that on September 2, 2019 our team participated in the #camelyon17 Grand Challenge for the first time! The goal of this challenge is to assess algorithms for state-of-the-art automated #detection and #classification of #breastcancer #metastases in whole-slide images of histological lymph node sections. Our #algorithm ’s performance measured with Cohen's k [...]

NIHR supports second wave of small business medtech innovations

By |2019-09-01T20:50:13+03:00January 15th, 2019|Categories: News|

15/1/2019: DeepMed IO Ltd secures  150K pounds from the NIHR i4i-connect  grant to develop an AI alpha-prototype for standardising breast cancer grading. https://www.nihr.ac.uk/news/nihr-supports-second-wave-of-small-business-medtech-innovations/20354

DeepMed IO Ltd revceives 1M pounds from the NHS Small Business Research Initiative (SBRI)

By |2019-09-01T20:41:26+03:00September 1st, 2018|Categories: News|

1/9/2018: DeepMed IO Ltd revceives 1M pounds from the NHS Small Business Research Initiative (SBRI) to develop an AI-powered decision support system for detecting metastases on lymph-nodes from cancer patients. https://sbrihealthcare.co.uk/company/deepmed-io/